New insights into stiff-person syndrome, advancing diagnosis and treatment

Research explores the complexities of diagnosing and treating stiff-person syndrome, emphasizing the uncertain role of GAD antibodies and the promise of novel therapies.

Synexa Life Sciences enrols in My Green Lab certification program

Synexa Life Sciences, a global provider of biomarker and bioanalytical solutions to the pharmaceutical, biotech, and CRO industries, proudly announces its enrolment in the My Green

August 28, 2024

Prehospital Tranexamic Acid Won’t Stave Off Disability After Severe Trauma

Initiated before hospital admission in advanced trauma systems, tranexamic acid provided an early survival benefit that ultimately failed to translate into favorable 6-month outcomes in

June 15, 2023

Biological clocks could be the key to longer, healthier lives. But scientists don’t yet agree on what ‘aging’ is

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.